FDA Approves World s First Combo Insulin Pump And Glucose Monitor For Diabetes Device Alerts Users When Glucose Gets Too High Or Low
Below is a MRR and PLR article in category Health Fitness -> subcategory Diabetes.
FDA Approves Groundbreaking Combo Insulin Pump and Glucose Monitor for Diabetes
For those with insulin-dependent diabetes, managing blood glucose levels can be a daunting task. Thankfully, a new device is simplifying this process significantly.
A Revolutionary Device for Easier Diabetes Management
Dealing with diabetes often involves multiple daily insulin injections, frequent blood tests, and careful monitoring of diet and exercise impacts on blood sugar levels. However, the new Paradigm REAL-Time System by Medtronic offers a transformative solution.
This system combines a glucose sensor, transmitter, a smart insulin pump, and a glucose meter into a single device, providing users with enhanced control and health management.
Real-Life Impact
Chris Jarvis, a member of the 2004 Canadian Olympic Rowing Team, has firsthand experience with the challenges of type 1 diabetes, where the body fails to produce insulin naturally. Previously, during races, Jarvis would take up to 15 fingerstick measurements a day. He relied on separate devices to monitor glucose and administer insulin.
Now, Jarvis is using the newly approved Medtronic MiniMed Paradigm REAL-Time Insulin Pump and Continuous Glucose Monitoring System. This system administers insulin around the clock while continuously monitoring glucose levels, alerting users when levels are dangerously high or low.
Enhanced Control and Peace of Mind
"It's reassuring to know exactly what's happening in your body without relying on guesswork from sporadic fingersticks," Jarvis notes. "With just the touch of a button, I can see my blood sugar levels."
This innovative device empowers patients to gain deeper insight into how their lifestyle choices affect their blood sugar, enabling them to take swift preventive or corrective actions.
Expert Insights
Dr. Irl Hirsch, medical director at the University of Washington Diabetes Care Center, highlights that many insulin-dependent patients still use multiple daily insulin injections and depend on several fingerstick blood samples for glucose monitoring. This system revolutionizes management by delivering insulin continuously and providing almost 300 glucose readings daily.
"If you have insulin-dependent diabetes, precise insulin management and vigilant glucose monitoring are essential," Hirsch says. "This device is a significant breakthrough, being the first to handle both tasks."
The Importance of Accurate Monitoring
Research indicates that insulin pumps are more effective than multiple injections for controlling diabetes. Fingersticks often miss over 60% of low-glucose events, posing serious risks. If blood sugar levels become extremely high or low, patients can experience life-threatening comas. Long-term, uncontrolled glucose levels can lead to severe health issues like blindness, stroke, heart disease, and more.
“With the MiniMed Paradigm REAL-Time System, I manage my diabetes?"it doesn’t manage me,” Jarvis concludes.
This innovative device represents a major advancement in diabetes care, offering those with insulin-dependent diabetes greater freedom and improved quality of life.
You can find the original non-AI version of this article here: FDA Approves World s First Combo Insulin Pump And Glucose Monitor For Diabetes Device Alerts Users When Glucose Gets Too High Or Low.
You can browse and read all the articles for free. If you want to use them and get PLR and MRR rights, you need to buy the pack. Learn more about this pack of over 100 000 MRR and PLR articles.